3-Hydroxyisobutyrate, A Strong Marker of Insulin Resistance in Type 2 Diabetes and Obesity That Modulates White and Brown Adipocyte Metabolism
Overview
Authors
Affiliations
Circulating branched-chain amino acids (BCAAs) associate with insulin resistance and type 2 diabetes. 3-Hydroxyisobutyrate (3-HIB) is a catabolic intermediate of the BCAA valine. In this study, we show that in a cohort of 4,942 men and women, circulating 3-HIB is elevated according to levels of hyperglycemia and established type 2 diabetes. In complementary cohorts with measures of insulin resistance, we found positive correlates for circulating 3-HIB concentrations with HOMA2 of insulin resistance, as well as a transient increase in 3-HIB followed by a marked decrease after bariatric surgery and weight loss. During differentiation, both white and brown adipocytes upregulate BCAA utilization and release increasing amounts of 3-HIB. Knockdown of the 3-HIB-forming enzyme 3-hydroxyisobutyryl-CoA hydrolase decreases release of 3-HIB and lipid accumulation in both cell types. Conversely, addition of 3-HIB to white and brown adipocyte cultures increases fatty acid uptake and modulated insulin-stimulated glucose uptake in a time-dependent manner. Finally, 3-HIB treatment decreases mitochondrial oxygen consumption and generation of reactive oxygen species in white adipocytes, while increasing these measures in brown adipocytes. Our data establish 3-HIB as a novel adipocyte-derived regulator of adipocyte subtype-specific functions strongly linked to obesity, insulin resistance, and type 2 diabetes.
Che L, Liu L, Xu M, Fan Z, Niu L, Chen Y Front Nutr. 2025; 11():1524738.
PMID: 39867557 PMC: 11757131. DOI: 10.3389/fnut.2024.1524738.
Bo T, Fujii J Molecules. 2025; 30(1.
PMID: 39795113 PMC: 11721030. DOI: 10.3390/molecules30010056.
Single-cell view and a novel protective macrophage subset in perivascular adipose tissue in T2DM.
Li J, Tian Z, Zhang T, Jin J, Zhang X, Xie P Cell Mol Biol Lett. 2024; 29(1):148.
PMID: 39627688 PMC: 11616190. DOI: 10.1186/s11658-024-00668-5.
Antikainen A, Mutter S, Harjutsalo V, Thorn L, Groop P, Sandholm N Cardiovasc Diabetol. 2024; 23(1):425.
PMID: 39593124 PMC: 11590341. DOI: 10.1186/s12933-024-02512-8.
A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites.
Moya-Garzon M, Wang M, Li V, Lyu X, Wei W, Tung A Cell. 2024; 188(1):175-186.e20.
PMID: 39536746 PMC: 11724754. DOI: 10.1016/j.cell.2024.10.032.